Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake
Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake
Agonist lead identification for the high affinity niacin receptor GPR109a
作者:Tawfik Gharbaoui、Philip J. Skinner、Young-Jun Shin、Claudia Averbuj、Jae-Kyu Jung、Benjamin R. Johnson、Tracy Duong、Marc Decaire、Jane Uy、Martin C. Cherrier、Peter J. Webb、Susan Y. Tamura、Ning Zou、Nathalie Rodriguez、P. Douglas Boatman、Carleton R. Sage、Andrew Lindstrom、Jerry Xu、Thomas O. Schrader、Brian M. Smith、Ruoping Chen、Jeremy G. Richman、Daniel T. Connolly、Steven L. Colletti、James R. Tata、Graeme Semple
DOI:10.1016/j.bmcl.2007.06.028
日期:2007.9
A strategy for lead identification of new agonists of GPR109a, starting from known compounds shown to activate the receptor, is described. Early compound triage led to the formulation of a binding hypothesis and eventually to our focus on a series of pyrazole acid derivatives. Further elaboration of these compounds provided a series of 5,5-fused pyrazoles to be used as lead compounds for further optimization. (C) 2007 Elsevier Ltd. All rights reserved.
Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake